Safety and Tolerability of GBR 900 in a Single Ascending Dose Study in Healthy Subjects
Clinical trial NCT02235727 · COMPLETED
Trial details
- NCT number
- NCT02235727
- Sponsor
- Glenmark Pharmaceuticals Ltd. India
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-07-01
- Primary completion
- 2016-11-01
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.